Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
Glioblastoma (GBM) is the most common brain tumor, with rapid proliferation and fatal invasiveness.Large-scale genetic and epigenetic profiling studies have identified targets among molecular subgroups, yet agents developed against these targets have failed in late clinical development.We obtained the genomic and clinical data of GBM patients from